Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

Summary

The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.

Conditions

• Gastroenteritis

Interventions

DRUG

LGG

LGG 10\^10 cfu PO BID X 5 days

DRUG

micro-crystalline cellulose

1 capsule PO bid x 5 days

Sponsors & Collaborators

• Columbia University

  collaborator OTHER

• Northwestern University

  collaborator OTHER

• University of New Mexico

  collaborator OTHER

• Children's National Research Institute

  collaborator OTHER

• University of Utah

  collaborator OTHER

• Wayne State University

  collaborator OTHER

• Children's Hospital Medical Center, Cincinnati

  collaborator OTHER

• University of Michigan

  collaborator OTHER

• Brown University

  collaborator OTHER

• University of California, Davis

  collaborator OTHER

• Washington University School of Medicine

  lead OTHER

Principal Investigators

• Kimberly Quayle, MD · Washington University School of Medicine

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

3 Months

Max Age

48 Months

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-07-31

Primary Completion

2018-08-31

Completion

2018-08-31

Countries

• United States

Study Locations